ScoreWhy is Henan Taloph Pharmaceutical Stock Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 2.63%
- The company has been able to generate a Return on Capital Employed (avg) of 2.63% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 5.39% and Operating profit at -8.07% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 1.46% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 5.39% and Operating profit at -8.07% over the last 5 years
4
The company has declared Negative results for the last 3 consecutive quarters
- INTEREST(HY) At CNY 29.97 MM has Grown at 10.22%
- PRE-TAX PROFIT(Q) At CNY 2.54 MM has Fallen at -83.45%
- NET PROFIT(Q) At CNY 1.39 MM has Fallen at -93.54%
5
With ROE of 2.58%, it has a very expensive valuation with a 2.24 Price to Book Value
- Over the past year, while the stock has generated a return of 59.48%, its profits have fallen by -63.5%
- At the current price, the company has a high dividend yield of 0.2
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Henan Taloph Pharmaceutical Stock Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Henan Taloph Pharmaceutical Stock Co., Ltd.
59.48%
2.35
39.06%
China Shanghai Composite
14.77%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.39%
EBIT Growth (5y)
-8.07%
EBIT to Interest (avg)
1.01
Debt to EBITDA (avg)
6.01
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.81
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
30.84%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.63%
ROE (avg)
1.46%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
87
Industry P/E
Price to Book Value
2.24
EV to EBIT
62.91
EV to EBITDA
31.65
EV to Capital Employed
1.75
EV to Sales
2.62
PEG Ratio
NA
Dividend Yield
0.16%
ROCE (Latest)
2.79%
ROE (Latest)
2.58%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 107.41 MM
RAW MATERIAL COST(Y)
Fallen by -3.12% (YoY
-38What is not working for the Company
INTEREST(HY)
At CNY 29.97 MM has Grown at 10.22%
PRE-TAX PROFIT(Q)
At CNY 2.54 MM has Fallen at -83.45%
NET PROFIT(Q)
At CNY 1.39 MM has Fallen at -93.54%
DEBT-EQUITY RATIO
(HY)
Highest at 51.04 %
INTEREST COVERAGE RATIO(Q)
Lowest at 109.58
OPERATING PROFIT MARGIN(Q)
Lowest at 4.89 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.53%
NET SALES(Q)
Lowest at CNY 321.7 MM
OPERATING PROFIT(Q)
Lowest at CNY 15.73 MM
EPS(Q)
Lowest at CNY 0
Here's what is working for Henan Taloph Pharmaceutical Stock Co., Ltd.
Operating Cash Flow
Highest at CNY 107.41 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -3.12% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Henan Taloph Pharmaceutical Stock Co., Ltd.
Net Sales
At CNY 321.7 MM has Fallen at -35.2%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 2.54 MM has Fallen at -83.45%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 1.39 MM has Fallen at -93.54%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 29.97 MM has Grown at 10.22%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 109.58
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit Margin
Lowest at 4.89 % and Fallen
In each period in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debt-Equity Ratio
Highest at 51.04 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Net Sales
Lowest at CNY 321.7 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY 15.73 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
EPS
Lowest at CNY 0
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Debtors Turnover Ratio
Lowest at 1.53%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
